Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.

Ismail NA, Mvusi L, Nanoo A, Dreyer A, Omar SV, Babatunde S, Molebatsi T, van der Walt M, Adelekan A, Deyde V, Ihekweazu C, Madhi SA.

Lancet Infect Dis. 2018 Jul;18(7):779-787. doi: 10.1016/S1473-3099(18)30222-6. Epub 2018 Apr 21.

2.

New Biomarkers of Innate and Adaptive Immunity in Infectious Diseases.

Morzunov S, Deyde V, Abrahamyan L.

J Immunol Res. 2017;2017:7047405. doi: 10.1155/2017/7047405. Epub 2017 Dec 14. No abstract available.

3.

Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.

Jean Louis F, Buteau J, François K, Hulland E, Domerçant JW, Yang C, Boncy J, Burris R, Pelletier V, Wagar N, Deyde V, Lowrance DW, Charles M.

PLoS One. 2018 Jan 30;13(1):e0192077. doi: 10.1371/journal.pone.0192077. eCollection 2018.

4.

Trends in Tuberculosis Case Notification and Treatment Success, Haiti, 2010-2015.

Charles M, Richard M, Joseph P, Bury MR, Perrin G, Louis FJ, Fitter DL, Marston BJ, Deyde V, Boncy J, Morose W, Pape JW, Lowrance DW.

Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):49-56. doi: 10.4269/ajtmh.16-0863.

5.

Retention Throughout the HIV Care and Treatment Cascade: From Diagnosis to Antiretroviral Treatment of Adults and Children Living with HIV-Haiti, 1985-2015.

Auld AF, Valerie Pelletier, Robin EG, Shiraishi RW, Dee J, Antoine M, Desir Y, Desforges G, Delcher C, Duval N, Joseph N, Francois K, Griswold M, Domercant JW, Patrice Joseph YA, Van Onacker JD, Deyde V, Lowrance DW, And The Groupe d'Analyses Salvh.

Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):57-70. doi: 10.4269/ajtmh.17-0116.

6.

Building and Rebuilding: The National Public Health Laboratory Systems and Services Before and After the Earthquake and Cholera Epidemic, Haiti, 2009-2015.

Jean Louis F, Buteau J, Boncy J, Anselme R, Stanislas M, Nagel MC, Juin S, Charles M, Burris R, Antoine E, Yang C, Kalou M, Vertefeuille J, Marston BJ, Lowrance DW, Deyde V.

Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):21-27. doi: 10.4269/ajtmh.16-0941.

7.

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.

Hunt GM, Dokubo EK, Takuva S, de Oliveira T, Ledwaba J, Dube N, Moodley P, Sabatier J, Deyde V, Morris L, Raizes E.

J Antimicrob Chemother. 2017 Nov 1;72(11):3141-3148. doi: 10.1093/jac/dkx252. Erratum in: J Antimicrob Chemother. 2017 Nov 1;72(11):3222.

PMID:
28981637
8.

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.

Hunt GM, Kainne Dokubo E, Takuva S, de Oliveira T, Ledwaba J, Dube N, Moodley P, Sabatier J, Deyde V, Morris L, Raizes E.

J Antimicrob Chemother. 2017 Nov 1;72(11):3222. doi: 10.1093/jac/dkx340. No abstract available.

PMID:
28961961
9.

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

Auld AF, Shiraishi RW, Oboho I, Ross C, Bateganya M, Pelletier V, Dee J, Francois K, Duval N, Antoine M, Delcher C, Desforges G, Griswold M, Domercant JW, Joseph N, Deyde V, Desir Y, Van Onacker JD, Robin E, Chun H, Zulu I, Pathmanathan I, Dokubo EK, Lloyd S, Pati R, Kaplan J, Raizes E, Spira T, Mitruka K, Couto A, Gudo ES, Mbofana F, Briggs M, Alfredo C, Xavier C, Vergara A, Hamunime N, Agolory S, Mutandi G, Shoopala NN, Sawadogo S, Baughman AL, Bashorun A, Dalhatu I, Swaminathan M, Onotu D, Odafe S, Abiri OO, Debem HH, Tomlinson H, Okello V, Preko P, Ao T, Ryan C, Bicego G, Ehrenkranz P, Kamiru H, Nuwagaba-Biribonwoha H, Kwesigabo G, Ramadhani AA, Ng'wangu K, Swai P, Mfaume M, Gongo R, Carpenter D, Mastro TD, Hamilton C, Denison J, Wabwire-Mangen F, Koole O, Torpey K, Williams SG, Colebunders R, Kalamya JN, Namale A, Adler MR, Mugisa B, Gupta S, Tsui S, van Praag E, Nguyen DB, Lyss S, Le Y, Abdul-Quader AS, Do NT, Mulenga M, Hachizovu S, Mugurungi O, Barr BAT, Gonese E, Mutasa-Apollo T, Balachandra S, Behel S, Bingham T, Mackellar D, Lowrance D, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):558-563. doi: 10.15585/mmwr.mm6621a3.

10.

Epidemiology of Epidemic Ebola Virus Disease in Conakry and Surrounding Prefectures, Guinea, 2014-2015.

Rico A, Brody D, Coronado F, Rondy M, Fiebig L, Carcelen A, Deyde VM, Mesfin S, Retzer KD, Bilivogui P, Keita S, Dahl BA.

Emerg Infect Dis. 2016 Feb;22(2):178-83. doi: 10.3201/eid2202.151304.

11.

Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.

Lecher S, Ellenberger D, Kim AA, Fonjungo PN, Agolory S, Borget MY, Broyles L, Carmona S, Chipungu G, De Cock KM, Deyde V, Downer M, Gupta S, Kaplan JE, Kiyaga C, Knight N, MacLeod W, Makumbi B, Muttai H, Mwangi C, Mwangi JW, Mwasekaga M, Ng'Ang'A LW, Pillay Y, Sarr A, Sawadogo S, Singer D, Stevens W, Toure CA, Nkengasong J.

MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1287-90. doi: 10.15585/mmwr.mm6446a3.

12.

Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.

Kharsany AB, Cawood C, Khanyile D, Grobler A, Mckinnon LR, Samsunder N, Frohlich JA, Abdool Karim Q, Puren A, Welte A, George G, Govender K, Toledo C, Chipeta Z, Zembe L, Glenshaw MT, Madurai L, Deyde VM, Bere A.

BMC Public Health. 2015 Nov 20;15:1149. doi: 10.1186/s12889-015-2179-2.

13.

Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011.

Younan M, Poh MK, Elassal E, Davis T, Rivailler P, Balish AL, Simpson N, Jones J, Deyde V, Loughlin R, Perry I, Gubareva L, ElBadry MA, Truelove S, Gaynor AM, Mohareb E, Amin M, Cornelius C, Pimentel G, Earhart K, Naguib A, Abdelghani AS, Refaey S, Klimov AI, Donis RO, Kandeel A.

Emerg Infect Dis. 2013 Jan;19(1):43-50. doi: 10.3201/eid1901.121080.

14.

Monitoring seasonal influenza A evolution: rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay.

Jeng K, Massire C, Zembower TR, Deyde VM, Gubareva LV, Hsieh YH, Rothman RE, Sampath R, Penugonda S, Metzgar D, Blyn LB, Hardick J, Gaydos CA.

J Clin Virol. 2012 Aug;54(4):332-6. doi: 10.1016/j.jcv.2012.05.002. Epub 2012 Jun 4.

15.

Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010.

Shu B, Garten R, Emery S, Balish A, Cooper L, Sessions W, Deyde V, Smith C, Berman L, Klimov A, Lindstrom S, Xu X.

Virology. 2012 Jan 5;422(1):151-60. doi: 10.1016/j.virol.2011.10.016. Epub 2011 Nov 10.

16.

An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses.

Shoji Y, Chichester JA, Palmer GA, Farrance CE, Stevens R, Stewart M, Goldschmidt L, Deyde V, Gubareva L, Klimov A, Mett V, Yusibov V.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:199-204.

PMID:
21922687
17.

Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation.

Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ, Lal RB, Sambhara S, Lal SK.

PLoS One. 2011;6(6):e20215. doi: 10.1371/journal.pone.0020215. Epub 2011 Jun 15.

18.

Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009.

Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS, Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR.

J Infect Dis. 2011 Mar 15;203(6):838-46. doi: 10.1093/infdis/jiq124.

19.

RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses.

Deyde VM, Sampath R, Gubareva LV.

Expert Rev Mol Diagn. 2011 Jan;11(1):41-52. doi: 10.1586/erm.10.107. Review.

PMID:
21171920
20.

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.

Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.

Antivir Ther. 2010;15(8):1151-9. doi: 10.3851/IMP1678.

PMID:
21149922
21.

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

Sheu TG, Fry AM, Garten RJ, Deyde VM, Shwe T, Bullion L, Peebles PJ, Li Y, Klimov AI, Gubareva LV.

J Infect Dis. 2011 Jan 1;203(1):13-7. doi: 10.1093/infdis/jiq005.

22.

Genomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technology.

Deyde VM, Sampath R, Garten RJ, Blair PJ, Myers CA, Massire C, Matthews H, Svoboda P, Reed MS, Pohl J, Klimov AI, Gubareva LV.

PLoS One. 2010 Oct 12;5(10):e13293. doi: 10.1371/journal.pone.0013293.

23.

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.

Ranjan P, Jayashankar L, Deyde V, Zeng H, Davis WG, Pearce MB, Bowzard JB, Hoelscher MA, Jeisy-Scott V, Wiens ME, Gangappa S, Gubareva L, García-Sastre A, Katz JM, Tumpey TM, Fujita T, Sambhara S.

Virol J. 2010 May 21;7:102. doi: 10.1186/1743-422X-7-102.

24.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09. Epub 2010 Mar 29.

25.

Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.

Okomo-Adhiambo M, Demmler-Harrison GJ, Deyde VM, Sheu TG, Xu X, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 May;54(5):1834-41. doi: 10.1128/AAC.01608-09. Epub 2010 Mar 1.

26.

Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Mar;54(3):1102-10. doi: 10.1128/AAC.01417-09. Epub 2009 Dec 22.

27.

Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008.

Dharan NJ, Patton M, Siston AM, Morita J, Ramirez E, Wallis TR, Deyde V, Gubareva LV, Klimov AI, Bresee JS, Fry AM.

Emerg Infect Dis. 2009 Dec;15(12):1973-6. doi: 10.3201/eid1512.081644.

28.

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.

Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.

PMID:
19917319
29.

Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.

Deyde V, Garten R, Sheu T, Smith C, Myrick A, Barnes J, Xu X, Shaw M, Klimov A, Gubareva L.

Influenza Other Respir Viruses. 2009 Nov;3(6):297-314. doi: 10.1111/j.1750-2659.2009.00103.x.

30.

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

Sheu TG, Deyde VM, Garten RJ, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):354-60. doi: 10.1016/j.antiviral.2009.10.022. Epub 2009 Nov 1.

PMID:
19887086
31.

Influenza genome analysis using pyrosequencing method: current applications for a moving target.

Deyde VM, Gubareva LV.

Expert Rev Mol Diagn. 2009 Jul;9(5):493-509. doi: 10.1586/erm.09.21. Review.

PMID:
19580433
32.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

33.

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L.

N Engl J Med. 2009 Jun 18;360(25):2616-25. doi: 10.1056/NEJMoa0903812. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

34.

Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.

Deyde VM, Nguyen T, Bright RA, Balish A, Shu B, Lindstrom S, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2009 Mar;53(3):1039-47. doi: 10.1128/AAC.01446-08. Epub 2009 Jan 5.

35.

Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.

Earhart KC, Elsayed NM, Saad MD, Gubareva LV, Nayel A, Deyde VM, Abdelsattar A, Abdelghani AS, Boynton BR, Mansour MM, Essmat HM, Klimov A, Shuck-Lee D, Monteville MR, Tjaden JA.

J Infect Public Health. 2009;2(2):74-80. doi: 10.1016/j.jiph.2009.04.004. Epub 2009 May 27.

36.

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.

Deyde VM, Okomo-Adhiambo M, Sheu TG, Wallis TR, Fry A, Dharan N, Klimov AI, Gubareva LV.

Antiviral Res. 2009 Jan;81(1):16-24. doi: 10.1016/j.antiviral.2008.08.008. Epub 2008 Oct 7.

PMID:
18835410
37.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

38.

Detection of adamantane-resistant influenza on a microarray.

Townsend MB, Smagala JA, Dawson ED, Deyde V, Gubareva L, Klimov AI, Kuchta RD, Rowlen KL.

J Clin Virol. 2008 Jun;42(2):117-23. doi: 10.1016/j.jcv.2007.12.019. Epub 2008 Mar 4.

39.

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI.

J Infect Dis. 2007 Jul 15;196(2):249-57. Epub 2007 Jun 7.

PMID:
17570112
40.

N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport.

Erickson BR, Deyde V, Sanchez AJ, Vincent MJ, Nichol ST.

Virology. 2007 May 10;361(2):348-55. Epub 2007 Jan 2.

41.

Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST.

J Virol. 2006 Sep;80(17):8834-42.

42.

Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2.

Deyde VM, Rizvanov AA, Chase J, Otteson EW, St Jeor SC.

Virology. 2005 Jan 20;331(2):307-15.

43.

Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells.

Khaiboullina SF, Rizvanov AA, Deyde VM, St Jeor SC.

J Med Virol. 2005 Feb;75(2):267-75.

PMID:
15602733
44.
45.

HbHope/HbS and HbS/beta-thal double compound heterozygosity in a Mauritanian family: clinical and biochemical studies.

Deyde VM, Lo BB, Aw T, Fattoum S.

Ann Hematol. 2003 Jul;82(7):423-6. Epub 2003 May 23.

PMID:
12764548
46.

Hemoglobin A2' (HbA2delta') in the Mauritanian population: first results of a preliminary survey.

Deyde VM, Fattoum S, Lo BB, Plaseska D, Efremov GD.

Ann Hematol. 2002 Jul;81(7):386-8. Epub 2002 Jun 5.

PMID:
12185509
47.

Epidemiological profile of hemoglobinopathies in the Mauritanian population.

Deyde VM, Lo BB, Khalifa IO, Ly B, Ball A, Fattoum S.

Ann Hematol. 2002 Jun;81(6):320-1. Epub 2002 May 17.

PMID:
12107561

Supplemental Content

Support Center